Prevalence of methicillin-resistant Staphylococcus aureus in meat von de Boer, E., Zwartkruis-Nahuis, J.T.M., Wit, B., Huijsdens, X.W., de Neeling, A.J., Bosch, T., van Oosterom, R.A.A., Vila, A., Heuvelink, A.E.

Volltext

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours von Sternberg, C.N., de Mulder, P., Schornagel, J.H., Theodore, C., Fossa, S.D., van Oosterom, A.T., Witjes, J.A., Spina, M., van Groeningen, C.J., Duclos, B., Roberts, J.T., de Balincourt, C., Collette, L.

Volltext

Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of... von Debiec-Rychter, M., Dumez, H., Judson, I., Wasag, B., Verweij, J., Brown, M., Dimitrijevic, S., Sciot, R., Stul, M., Vranck, H., Scurr, M., Hagemeijer, A., Van Glabbeke, M., van Oosterom, A.T.

Volltext

Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11 von WILDIERS, H, GUETENS, G, DE BOECK, G, VERBEKEN, E, LANDUYT, B, LANDUYT, W, DE BRUIJN, E. A, VAN OOSTEROM, A. T

Volltext

Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Fac... von STERNBERG, C. N, DE MULDER, P. H. M, COLLETTE, L, SCHORNAGEL, J. H, THEODORE, C, FOSSA, S. D, VAN OOSTEROM, A. T, WITJES, F, SPINA, M, VAN GROENINGEN, C. J, DE BALINCOURT, C

Volltext

Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial von LE CESNE, A, BLAY, J. Y, COLLIN, F, JIMENO, J, DI PAOLA, E, VAN GLABBEKE, M, NIELSEN, O. S, JUDSON, I, VAN OOSTEROM, A, VERWEIJ, J, RADFORD, J, LORIGAN, P, RODENHUIS, S, RAY-COQUARD, I, BONVALOT, S

Volltext

Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A Europe... von VAN GLABBEKE, M, VAN OOSTEROM, A. T, OOSTERHUIS, J. W, MOURIDSEN, H, CROWTHER, D, SOMERS, R, VERWEIJ, J, SANTORO, A, BUESA, J, TURSZ, T

Volltext

Youth and social navigation in Zimbabwe’s informal economy: ‘Don’t end up on the wrong side von Oosterom, Marjoke A

Volltext

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORT... von Judson, I, Radford, J.A, Harris, M, Blay, J.-Y, van Hoesel, Q, le Cesne, A, van Oosterom, A.T, Clemons, M.J, Kamby, C, Hermans, C, Whittaker, J, Donato di Paola, E, Verweij, J, Nielsen, S

Volltext

A phase II trial with rosiglitazone in liposarcoma patients von DEBROCK, G, VANHENTENRIJK, V, SCIOT, R, DEBIEC-RYCHTER, M, OYEN, R, VAN OOSTEROM, A

Volltext

Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy von Blay, J-Y, van Glabbeke, M, Verweij, J, van Oosterom, A.T, Le Cesne, A, Oosterhuis, J.W, Judson, I, Nielsen, O.S

Volltext

Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselecte... von Verweij, J, van Oosterom, A, Blay, J.-Y, Judson, I, Rodenhuis, S, van der Graaf, W, Radford, J, Le Cesne, A, Hogendoorn, P.C.W, di Paola, E.D, Brown, M, Nielsen, O.S

Volltext

Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall von Pauwels, P, Debiec-Rychter, M, Stul, M, De Wever, I, Van Oosterom, A T, Sciot, R

Volltext

Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients wi... von Eskens, F.A.L.M, Dumez, H, Hoekstra, R, Perschl, A, Brindley, C, Böttcher, S, Wynendaele, W, Drevs, J, Verweij, J, van Oosterom, A.T

Volltext

ECGSIM: an interactive tool for studying the genesis of QRST waveforms von van Oosterom, A, Oostendorp, T F

Volltext

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study von van Oosterom, Allan T, Judson, Ian, Verweij, Jaap, Stroobants, Sigrid, di Paola, Eugenio Donato, Dimitrijevic, Sasa, Martens, Marc, Webb, Andrew, Sciot, Raf, Van Glabbeke, Martine, Silberman, Sandra, Nielsen, Ole S

Volltext

Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft... von van Oosterom, A.T, Mouridsen, H.T, Nielsen, O.S, Dombernowsky, P, Krzemieniecki, K, Judson, I, Svancarova, L, Spooner, D, Hermans, C, Van Glabbeke, M, Verweij, J

Volltext

Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients von DIRLX, L. Y, VERMEUEEN, P. B, PAWINSKI, A, PROVE, A, BENOY, I, DE POOTER, C, MARTIN, M, VAN OOSTEROM, A. T

Volltext

Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO von Blay, J.-Y., Bonvalot, S., Casali, P., Choi, H., Debiec-Richter, M., Dei Tos, A. P., Emile, J.-F., Gronchi, A., Hogendoorn, P. C. W., Joensuu, H., Le Cesne, A., Mac Clure, J., Maurel, J., Nupponen, N., Ray-Coquard, I., Reichardt, P., Sciot, R., Stroobants, S., van Glabbeke, M., van Oosterom, A., Demetri, G. D.

Volltext

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer von BRUNO, R, HILLE, D, RIGAS, J. R, SEIDMAN, A. D, CHEVALLIER, B, FUMOLEAU, P, BURRIS, H. A, RAVDIN, P. M, SHEINER, L. B, RIVA, A, VIVIER, N, TEN BOKKEL HUINNINK, W. W, VAN OOSTEROM, A. T, KAYE, S. B, VERWEIJ, J, FOSSELLA, F. V, VALERO, V

Volltext